Indoco Remedies Limited — Glimepiride Exporter Profile
Indian Pharmaceutical Exporter · #1 for Glimepiride · $2.0M export value · DGFT Verified
Indoco Remedies Limited is the #1 Indian exporter of Glimepiride with $2.0M in export value and 41 verified shipments. Indoco Remedies Limited holds a 2.7% market share in Glimepiride exports across 2 countries. The company exports 13 pharmaceutical products worth $73.5M across 9 therapeutic categories.
Indoco Remedies Limited — Glimepiride Export Profile: Buyers & Destinations
Where Does Indoco Remedies Limited Export Glimepiride?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.2M | 39 | 98.8% |
| PERU | $13.5K | 2 | 1.2% |
Indoco Remedies Limited exports Glimepiride to 2 countries. The largest destination is UNITED STATES accounting for 98.8% of Indoco Remedies Limited's Glimepiride shipments. These destinations reflect Indoco Remedies Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Glimepiride from India?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES, LLC | UNITED STATES | $1.3M | 51 |
| EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $905.2K | 25 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $780.5K | 109 |
| MEIJI SEIKA PHARMATECH CO LIMITED | JAPAN | $750.0K | 15 |
| AMERISOURCE HEALTH SERVICES | UNITED STATES | $704.6K | 38 |
| MEIJI SEIKA PHARMATECH CO., LTD | JAPAN | $650.0K | 13 |
| AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $600.0K | 12 |
| I.E. MEDICA INC. | PHILIPPINES | $574.6K | 15 |
| DR REDDYS LABORATORIES INC | UNITED STATES | $300.0K | 6 |
| XX REXXYS XXBORXXORIXX INXX | UNITED STATES | $100.0K | 2 |
India's Glimepiride is purchased by 535 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCE SERVICES LLC and APL SWIFT SERVICES (MALTA) LTD.,.
What Is India's Total Glimepiride Export Value and How Much Does Indoco Remedies Limited Contribute?
India exported $23.4M worth of Glimepiride through 3,159 shipments from 242 suppliers to 94 countries, serving 535 buyers globally. Indoco Remedies Limited contributes $2.0M to this total, accounting for 2.7% of India's Glimepiride exports. Indoco Remedies Limited ships Glimepiride to 2 countries through 0 buyers.
What Is the Average Shipment Value for Indoco Remedies Limited's Glimepiride Exports?
Indoco Remedies Limited's average Glimepiride shipment value is $50.0K per consignment, based on 41 shipments totaling $2.0M. The largest destination is UNITED STATES (98.8% of Indoco Remedies Limited's Glimepiride exports).
How Does Indoco Remedies Limited Compare to Other Indian Glimepiride Exporters?
Indoco Remedies Limited ranks #1 among 242 Indian Glimepiride exporters with a 2.7% market share. The top 3 exporters are MICRO LABS LIMITED ($5.3M), IPCA LABORATORIES LIMITED ($3.6M), INVENTIA HEALTHCARE LIMITED ($3.0M). Indoco Remedies Limited processed 41 shipments to 2 destination countries.
What Glimepiride Formulations Does Indoco Remedies Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GLIMEPIRIDE TABLETS 4MG, PACK OF 500 (Ea | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 1MG, PACK OF 500 (Ea | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 2MG, PACK OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 2MG) | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 4MG, PACK OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 4MG) | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 4MG, PACK OF 100 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 4MG) | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 2MG, PACK OF 100 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 2MG) | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDE USP 1MG) | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 2MG, PACK OF 500 [ EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDE USP 2MG][QTY: 22,536 CON X 500 EACH ] | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 4MG, PACK OF 500 [ EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDE USP 4MG][QTY: 22,704 CON X 500 EACH ] | $50.0K | 1 |
| GLIMEPIRIDE TABLETS 4MG, PACK OF 500 [ EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDE USP 4MG][QTY: 29,136 CON X 500 EACH ] | $50.0K | 1 |
Indoco Remedies Limited exports 40 distinct Glimepiride formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLIMEPIRIDE TABLETS 4MG, PACK OF 500 (Ea with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Glimepiride to Key Markets
What Indoco Remedies Limited must comply with to export Glimepiride to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Indoco Remedies Limited Compare to Nearest Glimepiride Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | INVENTIA HEALTHCARE LIMITED | $3.0M | 108 | 6 | $27.6K |
| 5 | MEDREICH LIMITED | $2.1M | 42 | 1 | $50.0K |
| 1 | INDOCO REMEDIES LIMITED ★ | $2.0M | 41 | 2 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.6M | 66 | 4 | $23.6K |
| 8 | MYLAN LABORATORIES LIMITED | $1.3M | 86 | 4 | $14.8K |
Indoco Remedies Limited ranks #1 among 242 Indian Glimepiride exporters. Average shipment value of $50.0K compared to the market average of $96.6K. The closest competitors by value are INVENTIA HEALTHCARE LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Glimepiride Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 350 | 11.1% |
| NHAVA SHEVA SEA (INNSA1) | 268 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 241 | 7.6% |
| DELHI AIR CARGO ACC (INDEL4) | 228 | 7.2% |
| DELHI AIR | 226 | 7.2% |
| JNPT/ NHAVA SHEVA SEA | 172 | 5.4% |
| BANGALORE ACC (INBLR4) | 148 | 4.7% |
| BANGALORE AIR | 110 | 3.5% |
Geopolitical & Trade Policy Impact on Indoco Remedies Limited's Glimepiride Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Indoco Remedies. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times. These maritime challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of new tariffs by the US administration, with rates reaching up to 39% on imports from countries including India, poses a significant threat. These tariffs could affect approximately 55% of India's exports to the US, compelling companies like Indoco to reassess pricing strategies and explore new markets to mitigate potential revenue losses. (apnews.com)
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, demand enhanced compliance measures from exporters. For Indoco, this necessitates investments in serialization and traceability technologies to ensure continued access to the EU market.
Indoco Remedies Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Indoco Remedies has faced challenges in this arena; for instance, the company's Goa sterile facility was placed under Official Action Indicated status by the USFDA, indicating significant compliance issues. Such regulatory setbacks can impede market access and necessitate substantial remediation efforts. (alphastreet.com)
The broader Indian pharmaceutical industry has also encountered increased scrutiny, with the USFDA conducting over 200 inspections in 2023 and planning to escalate this number in 2024. This heightened oversight underscores the critical importance of stringent quality control and compliance measures for companies like Indoco to maintain and expand their export markets. (fact.net.in)
About Indoco Remedies Limited
Indoco Remedies Limited exports 13 products worth $73.5M. Beyond Glimepiride, top products include Allopurinol, Paracetamol, Tramadol, Albendazole, Montelukast. View the complete Indoco Remedies Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Indoco Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 41 individual customs records matching Indoco Remedies Limited exporting Glimepiride, covering 40 formulations to 2 countries via 0 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glimepiride Export Data from Indoco Remedies Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Indoco Remedies Limited's Glimepiride exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Indoco Remedies Limited
Full Company Profile →
13 products · $73.5M total trade · 9 categories
Glimepiride Stats
Company Overview
Top Products by Indoco Remedies Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Indoco Remedies Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glimepiride. For current shipment-level data, contact TransData Nexus.